<DOC>
	<DOCNO>NCT01834963</DOCNO>
	<brief_summary>To evaluate efficacy safety postoperative hepatic arterial infusion chemotherapy , interferon/fluorouracil versus low-dose cisplatin/fluorouracil , patient hepatocellular carcinoma portal vein tumor thrombus .</brief_summary>
	<brief_title>P2 Study Postoperative Interferon/Fluorouracil v Cisplatin/Fluorouracil Hepatocellular Carcinoma .</brief_title>
	<detailed_description>No standard treatment establish highly advanced hepatocellular carcinoma ( HCC ) invade major branch portal vein except sorafenib . Some report suggest hepatic arterial infusion chemotherapy improve survival patient . Other report indicate surgical intervention improve survival . However , standard adjuvant therapy liver resection patient HCC portal vein tumor thrombus main first branch portal vein . Our preliminary result show combined interferon-alpha intra-arterial 5-fluorouracil ( 5-FU ) postoperative therapy prolong disease-free overall survival liver resection . Hepatic arterial infusion chemotherapy use low-dose 5-FU cisplatin also promise regimen advance HCC . Herein , investigator plan study evaluate efficacy ( two year survival primary outcome , overall-survival secondary outcome ) safety ( secondary outcome ) hepatic arterial infusion chemotherapy continuous infusion 5-fluorouracil systemic administration interferon-alpha low-dose 5-FU cisplatin , compare efficacy randomize control trial .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>1. hepatocellular carcinoma histological evidence typical finding CT MRI . 2. surgically resectable tumor tumor thrombus first branch main trunk portal vein . 3 . 20 year old . 4 . Eastern Cooperative Oncology Group Performance status 0 1 . 5 . Life expectancy least 6 month pretreatment evaluation . 6 . ChildPugh class A B . 7 . Adequate bone marrow , liver renal function , assess follow laboratory requirement . white blood cell count &gt; = 2000/microliter , Neutrophil &gt; = 1000/microliter , Hemoglobin &gt; = 9.0 g/dL , Platelet count &gt; = 75000/microliter , Total Bilirubin &lt; = 1.5mg/dl , aspartate aminotransferase ( AST ) /alanine aminotransferase ( ALT ) &lt; = 150 IU/L , Serum creatinine &lt; = 1.2mg/dL , Creatinine clearance &gt; = 60 ml/min 1 . Histological diagnose combined hepatocellular cholangiocellular carcinoma . 2 . Extrahepatic tumor spread affect patient 's prognosis . 3 . Hepatic encephalopathy 4 . Active infection except hepatitis B virus ( HBV ) hepatitis C virus ( HCV ) . 5 . Sever complication ( interstitial pneumonia , heart failure , renal failure , liver failure , ileus , incontrollable diabetes mellitus , ) 6 . Active double cancer 7 . Pregnancy 810 ) Medication treatment may affect absorption drug pharmacokinetics . 11 ) others , investigator 's judgment .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>